InvestorsHub Logo
Followers 44
Posts 4950
Boards Moderated 0
Alias Born 04/30/2005

Re: McMagyar post# 278077

Friday, 10/23/2020 11:21:39 AM

Friday, October 23, 2020 11:21:39 AM

Post# of 469805
Excellent post, McMagyer!

It's the perfect comparison because it's true: Biogen's share price would jump up an extra $30 Billion on the possibility that their crappy results might be effective and get FDA approval.

AVXL is about to stun the Alzheimer experts at CTAD with real data from our PDD phase 2 trial.

It's all down hill from here!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News